Sanofi India Limited is one of the entities through which Sanofi operates in India. It was incorporated in May 1956 under the name Hoechst Fedco Pharma Private Limited. Over the years, its name was changed to Hoechst Pharmaceuticals Private Limited, Hoechst India Limited, Hoechst Marion Roussel Limited and Aventis Pharma Limited. Today, it employs more than 3,000 employees across India. Sanofi, one of the world's leading healthcare companies, and its 100% subsidiary - Hoechst GmbH, are the major shareholders of Sanofi India Limited and together hold 60.4% of its paid-up share capital. The shares of Sanofi India Limited are quoted on the Bombay Stock Exchange (Security Code: 500674) and the National Stock Exchange (Security Code: Sanofi). We have two manufacturing sites – 1 in Hyderabad and 1 in Goa. These sites manufacture products with the stringent global quality guidelines, also approved by regulatory agencies such as Medicines and Healthcare Products Regulatory Agency (MHRA) from United Kingdom, Regierungspräsidium Darmstadt from Germany, Medicines Control Council (MCC) from South Africa, Taiwan Food & Drug Administration (TFDA) from Taiwan, State Administration of Ukraine on Medicinal Products (SAUMP) from Ukraine, Therapeutic Goods Administration (TGA) from Australia, Health Authority from Canada, Agência Nacional de Vigilância Sanitária (ANVISA) from Brazil, and Pharmacy & Poisons Board (PPB) from Kenya. In addition to these, regulatory approvals as per Indian Legislation also endorse the quality and safety of the products manufactured at our sites. Sanofi India Limited also manufactures its products through third party manufacturers. The different types of dosage forms include tablets, capsules (hard and soft), Eye/Ear drops, ampoules, vials, creams and ointments. These products are manufactured in accordance with the same quality standards as those prevalent at its own manufacturing sites for domestic consumption and for export to Russia, the Ukraine and other CIS countries.